The Perfect Fit for Nucleic Acid Therapeutics

Comprehensive pDNA and mRNA Solutions Made For You

Nucleic acid therapeutics (NATs) are DNA and RNA-based innovative approaches that aim to enable treatment of a wide variety of unmet diseases from genetic disorders to cancer and viral infections. Since COVID-19, mRNA-based therapies have gained widespread attention due to their potential for rapid development, adaptability and cost-effectiveness when compared to viral vector-based therapies. However, challenges remain to ensure efficient, targeted, safe and non-viral delivery of nucleic acids.  

We share you mission to simplify the development and manufacturing of RNA and DNA based therapeutics. From ready-to-use products designed to maximize efficiency and performance, to tailor-made services backed by extensive expertise and support, you can rest assured that our pDNA and mRNA solutions were made for you. With Sartorius, it’s always the perfect fit.
 

Solutions for Process Development and Manufacturing

Explore Comprehensive pDNA and mRNA Solutions in Every Step of Your Workflow. 
Click on each unit operation to learn more.

 

Featured Products & Services

Banner Ready-to-use Plasmids

Plasmid Engineering & Sequencing Service

Utilize our e-Zyvec® assembly technology to design & optimize plasmid sequences tailored to your specific applications.

Plasmid Manufacturing Service

Discover our plasmid DNA manufacturing services, offering scalable solutions in state-of-the-art GMP facilities.

Non-Viral Delivery Solutions

Explore our lipid library for LNPs and ready-to-use reagents for efficient and cost-effective in vivo and ex vivo nucleic acid delivery.

PATfix® mRNA Platform

Fast at-line monitoring of IVT reaction for reliable mRNA size and integrity quantification and detection of impurities such as dsRNA.

Highlight Asset

Infographics

Your mRNA Is Precious and So Is Your Time

Can mRNA formulation and delivery be more affordable, efficient and scalable? Review our infographic, which illustrates how we simplify and enhance yo...

Featured Assets

Webcast
Webinar

Advantages of Ready-to-use Lipid-Based Gene Delivery for Gene-Modified...

Explore a non-viral alternative for ex vivo transfection of immune and stem cells, designed to overcome the limitations of traditional gene delivery m...

Webcast
Webinar

Combining AI-Powered mRNA Design With Non-Viral Delivery

Explore how cationic lipid-based transfection coupled with AI-powered mRNA design can enhance expression and tissue specificity for in vivo RNA delive...

T cell releases antibodies, binding to virus
Article

Nucleic Acid Immunization for Rapid, Cost-Effective Antibody Discovery

Explore rapid antibody discovery with genetic immunization, leveraging Sartorius' innovative DNA/RNA tools and bioanalytical instruments.

Webinar

Optimizing mRNA Production

Learn more on how to achieve IVT yields of 25 g/L in batch mode and how to design an efficient fed-batch IVT reaction.

Computer-generated image of a glowing lightbulb with DNA filament surrounded by cells and neurons.
Article

Investigating the Dual Role of Plasmid DNA in Advanced Therapies

Plasmid DNA is key in advanced therapies, serving as both a drug substance and material for mRNA vaccines and gene therapies.

Article

Overview of RNA Delivery: Challenges and Innovation

Still delivery challenges remain, driving the need for ongoing innovations to develop more efficient and stable solutions.

Webinar

Beyond The Liver 

Learn about a novel lipid library opening new horizons for LNP developers.

Webinar

Integrated Production of mRNA from E. coli to Highly Purified mRNA

New mRNA purification approach for improved recovery, extra-low protein impurities, and efficient dsRNA removal.

Article

Scalable Alkaline Lysis for pDNA Production 

A fully automated in-line lysis system designed to increase control and efficiency of pDNA isolation.

icon-contact-us

Stay Up-to-Date

Sign up for our e-newsletter and stay up to date with the latest on nucleic acid therapeutics.

Sign Up for Newsletter

Consult Our Experts

Consult Our RNA & DNA Therapeutics Experts